$MGHL
MORGAN GROUP HOLDING CO

2023 Q4 Form 10-Q Financial Statement

#000114036123054031 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $487.0K
YoY Change 17.83%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $719.0K
YoY Change 19.37%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$232.0K
YoY Change 22.74%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$232.0K
YoY Change 22.74%
Net Earnings / Revenue -47.63%
Basic Earnings Per Share -$0.39
Diluted Earnings Per Share -$0.39
COMMON SHARES
Basic Shares Outstanding 600.1K 600.1K
Diluted Shares Outstanding 600.1K

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.290M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $5.189K
YoY Change -64.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.965M
YoY Change -43.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $766.2K
YoY Change -42.62%
SHAREHOLDERS EQUITY
Retained Earnings -$52.69M
YoY Change 1.84%
Common Stock $6.001K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.199M
YoY Change
Total Liabilities & Shareholders Equity $1.965M
YoY Change -43.6%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$232.0K
YoY Change 22.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11772
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6001
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53886180
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53886180
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51805127
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1198644
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2087054
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1964826
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3417716
CY2023Q3 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
462365
CY2022Q3 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
389823
us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
1366010
us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
1343225
CY2022Q3 mghl Principal Transactions
PrincipalTransactions
-188
mghl Principal Transactions
PrincipalTransactions
2108
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
87443
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
29758
CY2022Q3 us-gaap Revenues
Revenues
413316
us-gaap Revenues
Revenues
1453210
us-gaap Revenues
Revenues
1397344
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
294354
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
274908
us-gaap Clearance Fees
ClearanceFees
613370
us-gaap Clearance Fees
ClearanceFees
574067
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
199404
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
190994
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
653392
us-gaap Operating Expenses
OperatingExpenses
2284780
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-188991
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-888410
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-887436
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q4 us-gaap Deposits With Clearing Organizations And Others Securities
DepositsWithClearingOrganizationsAndOthersSecurities
350000
CY2023Q3 mghl Deferred Income Tax Assets Net Of Valuation Allowances And Deferred Tax Liability
DeferredIncomeTaxAssetsNetOfValuationAllowancesAndDeferredTaxLiability
0
CY2022Q4 mghl Deferred Income Tax Assets Net Of Valuation Allowances And Deferred Tax Liability
DeferredIncomeTaxAssetsNetOfValuationAllowancesAndDeferredTaxLiability
0
CY2023Q3 us-gaap Assets
Assets
1964826
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52693537
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-231970
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-188991
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2023Q3 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
170933
CY2023Q3 mghl Principal Transactions
PrincipalTransactions
124
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
24134
us-gaap Labor And Related Expense
LaborAndRelatedExpense
895492
CY2023Q3 us-gaap Clearance Fees
ClearanceFees
187573
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-231970
us-gaap Net Income Loss
NetIncomeLoss
-888410
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
63100
CY2022Q4 us-gaap Assets
Assets
3417716
CY2023Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
655
CY2022Q3 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
7760
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
1865
us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
16803
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
732306
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2087054
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276437
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1810617
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-380003
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-20655
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-505340
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
171
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
383846
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-995948
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-503590
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
350000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1639553
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2735307
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
13367
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-271785
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4200
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
339
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-44902
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-493189
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
300065
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-107538
mghl Principal Transactions
PrincipalTransactions
-7558
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
15545
CY2023Q3 us-gaap Revenues
Revenues
487030
CY2022Q3 us-gaap Clearance Fees
ClearanceFees
116057
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
37669
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
20348
us-gaap Occupancy Net
OccupancyNet
112406
us-gaap Occupancy Net
OccupancyNet
161829
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
719000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
602307
us-gaap Operating Expenses
OperatingExpenses
2341620
us-gaap Net Income Loss
NetIncomeLoss
-887436
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Net Income Loss
NetIncomeLoss
-888410
us-gaap Net Income Loss
NetIncomeLoss
-887436
us-gaap Depreciation
Depreciation
6583
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
mghl Number Of Nyse Member Firms Through Which All Securities Transactions Are Cleared
NumberOfNYSEMemberFirmsThroughWhichAllSecuritiesTransactionsAreCleared
3
mghl Underwriter Payment Receiving Maximum Period
UnderwriterPaymentReceivingMaximumPeriod
P90D
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001162283
dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q3 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/srt/2023#AffiliatedEntityMember
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/srt/2023#AffiliatedEntityMember
CY2023Q3 us-gaap Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
http://fasb.org/srt/2023#AffiliatedEntityMember
CY2022Q4 us-gaap Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
http://fasb.org/srt/2023#AffiliatedEntityMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-73996
dei Entity Registrant Name
EntityRegistrantName
Morgan Group Holding Co
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-4196940
dei Entity Address Address Line1
EntityAddressAddressLine1
401 Theodore Fremd Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Rye
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10580
dei City Area Code
CityAreaCode
914
dei Local Phone Number
LocalPhoneNumber
921-5216
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
MGHL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
600090
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1289553
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2285501
CY2022Q4 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
330621
CY2023Q3 us-gaap Other Receivables
OtherReceivables
22010
CY2022Q4 us-gaap Other Receivables
OtherReceivables
20190
CY2023Q3 us-gaap Deposits With Clearing Organizations And Others Securities
DepositsWithClearingOrganizationsAndOthersSecurities
350000
CY2023Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
18950
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
290785
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
69683
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5189
CY2023Q3 us-gaap Other Assets
OtherAssets
108191
CY2022Q4 us-gaap Other Assets
OtherAssets
128847
CY2023Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
200421
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
227098
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
933
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
594
CY2023Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
17583
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
62535
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
547245
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1040435
CY2023Q3 us-gaap Liabilities
Liabilities
766182
CY2022Q4 us-gaap Liabilities
Liabilities
1330662
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
6001
us-gaap Labor And Related Expense
LaborAndRelatedExpense
883538
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1430614
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-231970
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1198644
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3036245
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-347113
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2689132
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-351332
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2337800
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-188991
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2148809
us-gaap Depreciation
Depreciation
8206
us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
-159688
us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
159688
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1820
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-26677
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-251180
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1501
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-995948
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-503590
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2635501
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3238897
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1639553
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2735307
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1289553
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2385307
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
350000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Use of Estimates</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company’s financial statements are prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during that reporting period. Actual results could differ from those estimates.</div>
CY2023Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2022Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-231970
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-231970
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-188991
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-188991
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-888410
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-888410
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-887436
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-887436
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48

Files In Submission

Name View Source Status
mghl-20230930_cal.xml Edgar Link unprocessable
mghl-20230930_def.xml Edgar Link unprocessable
mghl-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
mghl-20230930_pre.xml Edgar Link unprocessable
0001140361-23-054031-index-headers.html Edgar Link pending
0001140361-23-054031-index.html Edgar Link pending
0001140361-23-054031.txt Edgar Link pending
0001140361-23-054031-xbrl.zip Edgar Link pending
ef20012487_10q.htm Edgar Link pending
ef20012487_ex31-1.htm Edgar Link pending
ef20012487_ex31-2.htm Edgar Link pending
ef20012487_ex32-1.htm Edgar Link pending
ef20012487_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mghl-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
ef20012487_10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending